CpG island methylator phenotype (CIMP) in microsatellite stable colorectal cancers; Differences between existing CIMP and newly described

被引：0
|
作者：
Lee, S.
Park, S. Y.
Kim, J. H.
Cho, N. Y.
Choi, M. H.
Yoo, E. J.
Kang, G. H.
机构：
[1] Kyung Hee Univ, Sch Med, Seoul, South Korea
[2] Seoul Natl Univ, Coll Med, Seoul, South Korea
来源：
LABORATORY INVESTIGATION | 2007年 / 87卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
540
引用
收藏
页码：120A / 121A
页数：2
相关论文
共 50 条
  • [41] Down-regulation of p21 (CDKNIA/CIP1) is inversely associated with microsatellite instability and CpG island methylator phenotype (CIMP) in colorectal cancer
    Ogino, S.
    Kawasaki, T.
    Kirkner, G. J.
    Ogawa, A.
    Dorfman, I.
    Loda, M.
    Fuchs, C. S.
    JOURNAL OF PATHOLOGY, 2006, 210 (02): : 147 - 154
  • [42] Colorectal Cancers (CRCs) With the CpG Island Methylator Phenotype (CIMP) Do Not Show Improved Survival With 5-Fluorouracil (5FU)-Based Adjuvant Chemotherapy
    Jover, Rodrigo
    Nguyen, Thuy-Phuong T.
    Perez-Carbonell, Lucia
    Paya, Artemio
    Alenda, Cristina
    Rojas, Estefania
    Castells, Antoni
    Andreu, Montserrat
    Llor, Xavier
    Boland, C. R.
    Goel, Ajay
    GASTROENTEROLOGY, 2010, 138 (05) : S102 - S102
  • [43] Chromosomally and microsatellite stable colorectal carcinomas without the CpG island methylator phenotype in a molecular classification
    Ostwald, Christiane
    Linnebacher, Michael
    Weirich, Volker
    Prall, Friedrich
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2009, 35 (02) : 321 - 327
  • [44] Clinicopathologic characteristics, CpG island methylator phenotype, and BRAF mutations in microsatellite-stable colorectal cancers without chromosomal instability
    Kakar, Sanjay
    Deng, Guoren
    Sahai, Vaibhav
    Matsuzaki, Koji
    Tanaka, Hirofumi
    Miura, Soichuro
    Kim, Young S.
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2008, 132 (06) : 958 - 964
  • [45] CpG island methylator phenotype and patients with multiple colorectal cancers.
    Grady, WM
    Markowitz, S
    Willis, J
    GASTROENTEROLOGY, 2000, 118 (04) : A46 - A46
  • [46] Molecular correlates with MGMT promoter methylation and silencing support CpG island methylator phenotype-low (CIMP-low) in colorectal cancer
    Ogino, Shuji
    Kawasaki, Takako
    Kirkner, Gregory J.
    Suemoto, Yuko
    Meyerhardt, Jeffrey A.
    Fuchs, Charles S.
    GUT, 2007, 56 (11) : 1564 - 1571
  • [47] A renal CpG island methylator phenotype (R-CIMP) in kidney tumors associated with germline mutations of FH and SDHB
    Ricketts, Christopher
    Killian, J. Keith
    Vocke, Cathy D.
    Sourbier, Carole
    Yang, Youfeng
    Merino, Maria J.
    Meltzer, Paul S.
    Linehan., W. Marston
    CANCER RESEARCH, 2016, 76
  • [48] Phase II study of nab-paclitaxel in refractory small bowel adenocarcinoma and CpG island methylator phenotype (CIMP)-high colorectal cancer
    Overman, M. J.
    Adam, L.
    Raghav, K.
    Wang, J.
    Kee, B.
    Fogelman, D.
    Eng, C.
    Vilar, E.
    Shroff, R.
    Dasari, A.
    Wolff, R.
    Morris, J.
    Karunasena, E.
    Pisanic, R., II
    Azad, N.
    Kopetz, S.
    ANNALS OF ONCOLOGY, 2018, 29 (01) : 139 - 144
  • [49] CpG island methylator phenotype-low (CIMP-low) colorectal cancer shows not only few methylated CIMP-high-specific CpG islands, but also low-level methylation at individual loci
    Kawasaki, Takako
    Ohnishi, Mutsuko
    Nosho, Katsuhiko
    Suemoto, Yuko
    Kirkner, Gregory J.
    Meyerhardt, Jeffrey A.
    Fuchs, Charles S.
    Ogino, Shuji
    MODERN PATHOLOGY, 2008, 21 (03) : 245 - 255
  • [50] Are clinicopathological features of colorectal cancers with methylation in half of CpG island methylator phenotype panel markers different from those of CpG island methylator phenotype-high colorectal cancers?
    Bae, Jeong Mo
    Rhee, Ye-Young
    Kim, Kyung Ju
    Wen, Xianyu
    Song, Young Seok
    Cho, Nam-Yun
    Kim, Jung Ho
    Kang, Gyeong Hoon
    HUMAN PATHOLOGY, 2016, 47 (01) : 85 - 94
12345